Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages

Journal of Investigative Dermatology

Volumn 135, Issue 11, 2015, Pages 2884-2887

  Fujimura, Taku ^a   Kambayashi, Yumi ^a   Furudate, Sadanori ^a   Asano, Masayuki ^a   Kakizaki, Aya ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CCL1 CHEMOKINE; CCL18 CHEMOKINE; CD163 ANTIGEN; COLONY STIMULATING FACTOR 1; EOTAXIN; EOTAXIN 2; EOTAXIN 3; INTERLEUKIN 4; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOID RELATED ORPHAN RECEPTOR GAMMA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; DENOSUMAB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR MARKER;

ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNOFLUORESCENCE; LETTER; MACROPHAGE ACTIVATION; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DENDRITIC CELL; DRUG EFFECTS; IN VITRO STUDY; MACROPHAGE; METABOLISM; PAGET DISEASE, EXTRAMAMMARY; PATHOPHYSIOLOGY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

BIOMARKERS, TUMOR; CELLS, CULTURED; CHEMOKINE CCL17; DENDRITIC CELLS; DENOSUMAB; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IN VITRO TECHNIQUES; MACROPHAGES; NF-KAPPA B; PAGET DISEASE, EXTRAMAMMARY; RANK LIGAND; REFERENCE VALUES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 84947038727     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.209     Document Type: Letter

References (12)

1. Anderson DM, Maraskovsky E, Billingsley WL et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390:175-9
2. Azim H, Azim HA Jr (2013) Targeting RANKL in breast cancer: bone metastasis and beyond. Expert Rev Anticancer Ther 13:195-201
3. Fujimura T, Furudate S, Kambayashi Y et al. (2013) Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical investigation. Clin Dev Immunol 2013:164982
4. Fujimura T, Kambayashi Y, Hidaka T et al. (2012) Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and noninvasive extramammary Paget's disease. Acta Derm Venereol 92:625-8
5. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32:593-604
6. Hao NB, Lu MH, Fan YH et al. (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012:948098
7. Kambayashi Y, Fujimura T, Furudate S et al. (2015) The possible interaction between receptor activator of nuclear factor kappa-B ligand (RANKL) expressed by extramammary Pagent cells and its ligand on dermal macrophages. J Invest Dermatol (in press)
8. Loser K, Mehling A, Loeser S et al. (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12: 1372-9
9. Martinez FO, Gordon S, Locati M et al. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303-11
10. Mantovani A, Sozzani S, Locati M et al. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-55
11. Wong BR, Josien R, Lee SY et al. (1997) TRANCE (tumor necrosis factor [TNF]-related activationinduced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186:2075-80
12. Yasuda H, Shima N, Nakagawa N et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-602